Policybazaar owner PB Fintech said on Thursday its new healthcare venture has raised $218 million in a seed round, marking its entry into India's fast-growing healthcare industry.

President Trump said Wednesday he would not pull back tariffs on Chinese goods in order to get China to the negotiating table ...

Despite conclusive proof of Abbvie sponsoring foreign tours for 30 doctors, violating marketing practices, the National ...

Vinay Prasad, a critic of the medical mainstream, will be the next director of the FDA center that regulates vaccines and ...

US executive order to speed up pharmaceutical plant approvals won't impact Indian industry due to various factors, experts ...

India's pharma market grew 7.8% in April 2025, driven by price hikes and chronic therapies, with top brands and segments like ...

The India–UK FTA is set to significantly boost bilateral trade to over $ 60 billion by 2030 through the elimination of ...

Benchmark stock indices Sensex and Nifty closed higher in a volatile session on Wednesday as India launched missile strikes on terrorist hideouts in Pakistan and Pakistan-Occupied Kashmir. After ...

Donald Trump's initiative to prioritize American-made prescription drugs poses significant challenges for Indian ...

The BSE Sensex on Wednesday gained by 105.71 points or 0.13% to close at 80,746.78, while the NSE Nifty rose 34.80 points or ...

The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for ...

CHENNAI: Concerns are mounting for the global pharmaceutical industry, particularly for Indian drug manufacturers that rely ...